PubRank

Kunihiko Tamaki

Author PubWeight™ 166.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan. Arch Dermatol 2004 2.62
2 Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol 2005 2.44
3 Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 2010 1.98
4 Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J Immunol 2005 1.81
5 Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 2002 1.75
6 Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. J Invest Dermatol 2006 1.64
7 The repeat domain of the melanosomal matrix protein PMEL17/GP100 is required for the formation of organellar fibers. J Biol Chem 2006 1.46
8 Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts. Am J Pathol 2006 1.46
9 Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 2006 1.33
10 Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J Clin Invest 2004 1.32
11 Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts. Arthritis Rheum 2005 1.32
12 Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 2004 1.24
13 CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol 2007 1.20
14 Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-beta1. Arch Dermatol Res 2002 1.19
15 CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes. Blood 2003 1.18
16 Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res 2005 1.16
17 Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts. J Immunol 2003 1.14
18 Mechanical stretching in vitro regulates signal transduction pathways and cellular proliferation in human epidermal keratinocytes. J Invest Dermatol 2004 1.14
19 Alpha2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts. Nucleic Acids Res 2005 1.12
20 Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein. FASEB J 2010 1.12
21 Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol 2009 1.12
22 Characterization and localization of side population cells in mouse skin. Stem Cells 2005 1.09
23 Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma. J Invest Dermatol 2006 1.09
24 Phosphatidylinositol 3-kinase is involved in alpha2(I) collagen gene expression in normal and scleroderma fibroblasts. J Immunol 2004 1.08
25 Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J Biol Chem 2005 1.06
26 A randomized double-blind trial of intravenous immunoglobulin for pemphigus. J Am Acad Dermatol 2009 1.06
27 Constitutive phosphorylation of focal adhesion kinase is involved in the myofibroblast differentiation of scleroderma fibroblasts. J Invest Dermatol 2005 1.03
28 LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. Blood 2010 1.03
29 Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 2003 1.02
30 B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Am J Pathol 2004 1.02
31 Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003 1.01
32 Prevalence of atopic dermatitis in Japanese adults and community validation of the U.K. diagnostic criteria. J Dermatol Sci 2009 1.00
33 Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol 2004 1.00
34 Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution. J Biol Chem 2002 1.00
35 Eotaxin gene single nucleotide polymorphisms in the promoter and exon regions are not associated with susceptibility to atopic dermatitis, but two of them in the promoter region are associated with serum IgE levels in patients with atopic dermatitis. J Dermatol Sci 2002 1.00
36 Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J Invest Dermatol 2004 1.00
37 Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma. J Invest Dermatol 2010 0.99
38 Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts. Am J Pathol 2004 0.98
39 CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. Int Immunol 2007 0.98
40 The secreted form of a melanocyte membrane-bound glycoprotein (Pmel17/gp100) is released by ectodomain shedding. FASEB J 2009 0.97
41 P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals. J Immunol 2011 0.96
42 Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts. Am J Pathol 2005 0.96
43 Japanese guideline for atopic dermatitis. Allergol Int 2011 0.96
44 Serum high molecular weight adiponectin levels are decreased in psoriasis patients. J Dermatol Sci 2009 0.96
45 Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts. J Invest Dermatol 2005 0.95
46 Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis. J Dermatol Sci 2006 0.95
47 Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci 2002 0.94
48 CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol 2010 0.94
49 Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma. Cytokine 2003 0.94
50 Skin manifestations of arsenicosis in two villages in Bangladesh. Int J Dermatol 2002 0.94
51 Prevalence of atopic dermatitis determined by clinical examination in Japanese adults. J Dermatol 2006 0.94
52 Laser treatment of 26 Japanese patients with Mongolian spots. Dermatol Surg 2008 0.94
53 Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis. J Dermatol Sci 2008 0.93
54 Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 2005 0.93
55 Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis. J Rheumatol 2002 0.93
56 CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli. Eur J Immunol 2008 0.92
57 Regulation of fibrogenic/fibrolytic genes by platelet-derived growth factor C, a novel growth factor, in human dermal fibroblasts. J Cell Physiol 2005 0.92
58 Interleukin-13 stimulates the transcription of the human alpha2(I) collagen gene in human dermal fibroblasts. J Biol Chem 2004 0.92
59 The human histocompatibility leukocyte antigen (HLA) haplotype is associated with the onset of postherpetic neuralgia after herpes zoster. Pain 2004 0.92
60 IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway. J Immunol 2002 0.91
61 CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli. Eur J Immunol 2006 0.90
62 Generalized eruptive syringoma. Pediatr Dermatol 2005 0.90
63 Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells. J Invest Dermatol 2005 0.90
64 Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 2007 0.90
65 B cell antigen receptor and CD40 differentially regulate CD22 tyrosine phosphorylation. J Immunol 2006 0.90
66 A keratin 10 gene mutation (Arg156Cys) in a Japanese patient with bullous congenital ichthyosiform erythroderma. J Dermatol 2002 0.90
67 Does thrombosis cause intravascular fasciitis? Acta Derm Venereol 2007 0.89
68 Community validation of the U.K. diagnostic criteria for atopic dermatitis in Japanese elementary schoolchildren. J Dermatol Sci 2007 0.89
69 Elevated serum CTACK/CCL27 levels in CTCL. J Invest Dermatol 2006 0.89
70 Blue naevus with pigment network-like structure on dermoscopy. Acta Derm Venereol 2008 0.89
71 The direct action of 1alpha,25(OH)2-vitamin D3 on purified mouse Langerhans cells. Cell Immunol 2007 0.88
72 Eccrine angiomatous hamartoma with massive mucin deposition. Eur J Dermatol 2005 0.88
73 Cholinergic urticaria successfully treated with scopolamine butylbromide. Int J Dermatol 2003 0.88
74 Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase/Akt-dependent and mediated by Ets family transcription factors. J Cell Physiol 2006 0.88
75 Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells. J Dermatol Sci 2003 0.87
76 Recurrent cutaneous eosinophilic vasculitis presenting as annular urticarial plaques. Acta Derm Venereol 2005 0.87
77 Variations in the human Th2-specific chemokine TARC gene. Immunogenetics 2003 0.86
78 Interleukin 15 induces the signals of epidermal proliferation through ERK and PI 3-kinase in a human epidermal keratinocyte cell line, HaCaT. Biochem Biophys Res Commun 2003 0.86
79 Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 2009 0.86
80 Serum thymic stromal lymphopoietin levels are not elevated in patients with atopic dermatitis. J Dermatol 2008 0.86
81 Epidermal growth factor induces fibronectin expression in human dermal fibroblasts via protein kinase C delta signaling pathway. J Invest Dermatol 2004 0.85
82 Potential regulatory elements of the constitutive up-regulated alpha2(I) collagen gene in scleroderma dermal fibroblasts. Biochem Biophys Res Commun 2006 0.85
83 Lymphatic dysfunction impairs antigen-specific immunization, but augments tissue swelling following contact with allergens. J Invest Dermatol 2011 0.85
84 Blocking MAPK signaling downregulates CCL21 in lymphatic endothelial cells and impairs contact hypersensitivity responses. J Invest Dermatol 2011 0.85
85 CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation. Cancer Res 2011 0.85
86 Expression of cellular prion-related protein by murine Langerhans cells and keratinocytes. J Dermatol Sci 2002 0.85
87 Epidermal growth factor affects the synthesis and degradation of type I collagen in cultured human dermal fibroblasts. Matrix Biol 2006 0.84
88 A probable case of Muckle-Wells syndrome. J Dermatol 2006 0.84
89 Activation of Akt by mechanical stretching in human epidermal keratinocytes. Exp Dermatol 2006 0.84
90 Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Pediatr Allergy Immunol 2009 0.84
91 Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. J Invest Dermatol 2005 0.84
92 Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation. Eur J Immunol 2010 0.84
93 Serum TARC/CCL17 levels are increased in dermatomyositis associated with interstitial lung disease. J Dermatol Sci 2010 0.83
94 Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase/Akt and the protein kinase C signaling pathways. J Invest Dermatol 2006 0.83
95 Mycosis fungoides with recurrent Hodgkin's lymphoma and diffuse large B-cell lymphoma. Acta Derm Venereol 2009 0.83
96 Type I interferons inhibit maturation and activation of mouse Langerhans cells. J Invest Dermatol 2005 0.83
97 IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line. Cytokine 2002 0.83
98 Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts. J Invest Dermatol 2005 0.83
99 Specificity in stress response: epidermal keratinocytes exhibit specialized UV-responsive signal transduction pathways. DNA Cell Biol 2003 0.83
100 Kimura's disease with prolonged history and prominent vascular involvement. Acta Derm Venereol 2005 0.82
101 Early inflammatory changes in the "perilesional skin" of psoriatic plaques: is there interaction between dendritic cells and keratinocytes? J Invest Dermatol 2007 0.82
102 Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary? J Dermatol Sci 2006 0.82
103 Interferon-18 gene polymorphism -137 G/C is associated with susceptibility to psoriasis vulgaris but not with atopic dermatitis in Japanese patients. J Dermatol Sci 2008 0.82
104 Mannose-binding lectin (MBL) single nucleotide polymorphism is not associated with atopic dermatitis in Japanese patients. J Dermatol 2005 0.81
105 Angiogenic cytokines in serum and cutaneous lesions of patients with polyarteritis nodosa. J Am Acad Dermatol 2005 0.81
106 Lack of association between the promoter polymorphisms at positions -308 and -238 of the tumor necrosis factor alpha gene and psoriasis vulgaris in Japanese patients. Dermatology 2003 0.81
107 Juvenile pustular psoriasis associated with steroid withdrawal syndrome due to topical corticosteroid. J Dermatol 2008 0.81
108 Langerhans cells exhibit low responsiveness to double-stranded RNA. Biochem Biophys Res Commun 2004 0.81
109 Decrease in circulating autotaxin by oral administration of prednisolone. Clin Chim Acta 2012 0.81
110 Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis. J Dermatol Sci 2004 0.81
111 Successful treatment of dermatomyositis with high-dose intravenous immunoglobulin. Acta Derm Venereol 2006 0.81
112 Histamine differentially regulates the production of Th1 and Th2 chemokines by keratinocytes through histamine H1 receptor. Cytokine 2011 0.81
113 Recent advances on pathogenesis and therapies in systemic sclerosis. Clin Rev Allergy Immunol 2007 0.81
114 Thymus and activation-regulated chemokine (TARC)/CC chemokine ligand (CCL) 17 accelerates wound healing by enhancing fibroblast migration. Exp Dermatol 2011 0.81
115 Treatment of 153 Japanese patients with Q-switched alexandrite laser. Lasers Med Sci 2007 0.81
116 Anti-p53 antibodies in patients with dermatomyositis/polymyositis. Clin Rheumatol 2006 0.80
117 Epidermal growth factor up-regulates transforming growth factor-beta receptor type II in human dermal fibroblasts via p38 mitogen-activated protein kinase pathway. Biochem Biophys Res Commun 2006 0.80
118 Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts. Arthritis Rheum 2007 0.80
119 Linear connective tissue nevus. Pediatr Dermatol 2007 0.80
120 Differential effects of LPS and TGF-beta on the production of IL-6 and IL-12 by Langerhans cells, splenic dendritic cells, and macrophages. Cytokine 2004 0.80
121 Lack of association of CCR4 single nucleotide polymorphism with atopic dermatitis in Japanese patients. Acta Derm Venereol 2004 0.80
122 CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27. Exp Dermatol 2006 0.80
123 Demonstration of TARC and CCR4 mRNA expression and distribution using in situ RT-PCR in the lesional skin of atopic dermatitis. J Dermatol 2003 0.80
124 CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction. Cytokine 2008 0.79
125 Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta. Int J Mol Med 2006 0.79
126 Interferon-gamma, a strong suppressor of cell proliferation, induces upregulation of keratin K6, one of the inflammatory- and proliferation-associated keratins. J Invest Dermatol 2002 0.79
127 Semaphorin 7A on keratinocytes induces interleukin-8 production by monocytes. J Dermatol Sci 2011 0.79
128 Cell type-specific regulation of the TGF-beta-responsive alpha2(I) collagen gene by CpG methylation. J Cell Physiol 2005 0.79
129 Epithelioid sarcoma associated with lung adenocarcinoma. J Dermatol 2005 0.78
130 Serum BAFF and APRIL levels in patients with alopecia areata. J Dermatol Sci 2008 0.78
131 High-dose intravenous immunoglobulin infusion in polyarteritis nodosa: report on one case and review of the literature. Clin Rheumatol 2005 0.78
132 Altered dynamics of transforming growth factor β(TGF-β) receptors in scleroderma fibroblasts. Ann Rheum Dis 2010 0.78
133 Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts. Arthritis Rheum 2002 0.78
134 Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris. J Dermatol Sci 2002 0.78
135 Serum levels of soluble CD21 in patients with systemic sclerosis. Rheumatol Int 2010 0.78
136 Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS. J Dermatol Sci 2003 0.78
137 Psoriasis arthropathica associated with severe obesity showing high serum leptin level. J Dermatol 2009 0.78
138 Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata. Arch Dermatol Res 2007 0.78
139 Detection of human herpesvirus-6 transcripts in carbamazepine-induced hypersensitivity syndrome by in situ hybridization. J Dermatol Sci 2009 0.78
140 α4β7 Integrin is essential for contact hypersensitivity by regulating migration of T cells to skin. J Allergy Clin Immunol 2010 0.78
141 Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts. Arthritis Rheum 2003 0.78
142 Successful treatment of Pyoderma gangrenosum with potassium iodide. Acta Derm Venereol 2006 0.78
143 Interesting response to concurrent chemoradiation in metastatic eccrine porocarcinoma. J Dermatol 2008 0.78
144 CC Chemokine Receptor 4 as a Possible Target for Therapy of Atopic Dermatitis. Drug News Perspect 2002 0.78
145 Serum levels of CCL17/TARC in various skin diseases. J Dermatol 2006 0.78
146 Prevalence of 52-kd and 60-kd Ro/SS-A autoantibodies in Japanese patients with polymyositis/dermatomyositis. J Am Acad Dermatol 2002 0.77
147 High levels of CCL26 in blister fluid and sera of patients with bullous pemphigoid. J Invest Dermatol 2011 0.77
148 IL-17F single nucleotide polymorphism is not associated with psoriasis vulgaris or atopic dermatitis in the Japanese population. J Dermatol Sci 2008 0.77
149 The development of Th1-mediated sarcoidosis improves the clinical course of Th2-mediated atopic dermatitis. Mod Rheumatol 2011 0.77
150 Folliculotropic mycosis fungoides with severe hepatic failure due to hepatic involvement. Acta Derm Venereol 2009 0.77
151 Evaluation of the treatment of port-wine stains with the 595-nm long pulsed dye laser: a large prospective study in adult Japanese patients. J Am Acad Dermatol 2006 0.77
152 Clinical features of scleroderma patients with contracture of phalanges. Clin Rheumatol 2006 0.77
153 TGF-beta1-mediated regulation of thymus and activation-regulated chemokine (TARC/CCL17) synthesis and secretion by HaCaT cells co-stimulated with TNF-alpha and IFN-gamma. J Dermatol Sci 2002 0.77
154 CXCL13 and CCL21 are expressed in ectopic lymphoid follicles in cutaneous lymphoproliferative disorders. J Invest Dermatol 2007 0.77
155 Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease. J Am Acad Dermatol 2007 0.77
156 Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma. Int J Dermatol 2005 0.77
157 The involvement of Gab1 and PI 3-kinase in beta1 integrin signaling in keratinocytes. Biochem Biophys Res Commun 2007 0.77
158 Human keratinocytes express fractalkine/CX3CL1. J Dermatol Sci 2003 0.77
159 ERK inhibitor PD98059 promotes the phenotypic and functional maturation of murine resident Langerhans cells. J Dermatol 2007 0.77
160 Comparison of prevalence of atopic dermatitis in Japanese elementary schoolchildren between 2001/2002 and 2007/2008. J Dermatol 2009 0.77
161 Mitogenic activity of dermatofibrosarcoma protuberans is mediated via an extracellular signal related kinase dependent pathway. J Invest Dermatol 2002 0.77
162 Ligation of E-cadherin molecules on murine resident Langerhans cells inhibits their maturation and chemokine production. J Dermatol Sci 2006 0.77
163 Gene mutation analysis in five cases of dermatofibrosarcoma protuberans using formalin-fixed, paraffin-embedded tissues. Acta Derm Venereol 2005 0.77
164 Roxithromycin downregulates production of CTACK/CCL27 and MIP-3α/CCL20 from epidermal keratinocytes. Arch Dermatol Res 2010 0.76
165 Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts. Arthritis Rheum 2005 0.76
166 Matrix metalloproteinase-9 expression in desmoplastic melanoma. J Dermatol 2008 0.76
167 The -431C>T polymorphism of thymus and activation-regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients. Exp Dermatol 2004 0.76
168 Square-shaped scleredema in the back: probably induced by mechanical stress. Int J Dermatol 2005 0.76
169 Reagents inducing epidermal proliferation also induce pigmentation: induction of keratinocyte proliferation as a novel strategy for the treatment of vitiligo. J Dermatol Sci 2013 0.76
170 Signaling through CD40 ligand decreases CD80 expression on murine Langerhans cells and enhances IL-12 p40 production. Biochem Biophys Res Commun 2005 0.76
171 Identification and characterization of the low-affinity receptor for immunoglobulin E (FcepsilonRII/CD23) on murine Langerhans cells. J Invest Dermatol 2002 0.76
172 Treatment of HIV-associated eosinophilic pustular folliculitis with narrow-band UVB. Int J Dermatol 2006 0.76
173 Long-term continuous versus intermittent cyclosporin: therapy for psoriasis. J Dermatol 2003 0.76
174 High calcium, ATP, and poly(I:C) augment the immune response to β-glucan in normal human epidermal keratinocytes. J Invest Dermatol 2011 0.76
175 Ultraviolet A irradiation inhibits thymus and activation-regulated chemokine (TARC/CCL17) production by a human keratinocyte HaCaT cell line. Eur J Dermatol 2003 0.76
176 Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris. Eur J Dermatol 2002 0.76
177 High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids. Eur J Dermatol 2002 0.76
178 Lack of association of CCR3 single nucleotide polymorphism with atopic dermatitis in Japanese population. J Dermatol Sci 2003 0.76
179 Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies. J Dermatol 2010 0.76
180 Treatment of psoriasis vulgaris with narrow-band UVB and topical Maxacalcitol. Acta Derm Venereol 2006 0.76
181 CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes. J Cell Physiol 2014 0.76
182 The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis. J Invest Dermatol 2003 0.76
183 Serum levels of matrix metalloproteinase-13 in patients with eosinophilic fasciitis. J Dermatol 2014 0.75
184 Identification of a novel marker for dendritic cell maturation, mouse transmembrane protein 123. J Biol Chem 2010 0.75
185 Cidofovir diphosphate inhibits molluscum contagiosum virus DNA polymerase activity. J Invest Dermatol 2007 0.75
186 Chronic active EB virus infection complicated with IgG3 subclass deficiency: an adult case treated with intravenous immunoglobulin and IFN-alpha. Acta Derm Venereol 2003 0.75
187 Cetirizine hydrochloride suppresses the CCL17 production of epidermal keratinocytes and dermal fibroblasts. Int J Dermatol 2012 0.75
188 Cysteinyl leukotriene receptor 2 gene polymorphism -1220 A/C is not associated with atopic dermatitis or psoriasis vulgaris in Japanese patients. J Dermatol 2010 0.75
189 Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia. Int J Dermatol 2006 0.75
190 Amyopathic dermatomyositis associated with esophageal cancer. Int J Dermatol 2008 0.75
191 Focal palmoplantar callosities in non-Herlitz junctional epidermolysis bullosa. J Am Acad Dermatol 2005 0.75
192 Necrolytic migratory erythema without glucagonoma in a patient with short bowel syndrome. J Dermatol 2006 0.75
193 Lipidized fibrous histiocytoma on the left condyle of the tibia. Int J Dermatol 2011 0.75
194 V alpha 24+ natural killer T cells are markedly decreased in atopic dermatitis patients. Hum Immunol 2003 0.75
195 Serum monocyte chemoattractant protein-1 is elevated in lepromatous leprosy patients with high bacterial indices. Int J Lepr Other Mycobact Dis 2002 0.75
196 Extramammary Paget's disease with intracytoplasmic lumen formation. J Dermatol 2009 0.75
197 Primary cutaneous anaplastic large cell lymphoma with leg involvement: a case report and review of 11 cases. J Dermatol 2011 0.75
198 High-frequency ultrasound as a useful device in the preliminary differentiation of lichen sclerosus et atrophicus from morphea. J Dermatol 2004 0.75
199 Psoriasis guttata in association with hepatocellular carcinoma. Acta Derm Venereol 2003 0.75
200 Detection of molluscum contagiosum virus gene transcripts by in situ hybridization. J Dermatol Sci 2009 0.75
201 Generalized morphea positive for anticentromere antibody. Eur J Dermatol 2008 0.75
202 [A female case of hyper-IgM immunodeficiency syndrome with uncommon skin manifestations]. Nihon Rinsho Meneki Gakkai Kaishi 2004 0.75
203 Anaplastic large cell lymphoma associated with parapsoriasis en plaques. Acta Derm Venereol 2008 0.75
204 Nuchal fibroma clearly visualized by computed tomography: a case report. Int J Dermatol 2005 0.75
205 Proliferating tricholemmal cystic carcinoma: a case containing differentiated and dedifferentiated parts. J Cutan Pathol 2008 0.75
206 Eosinophilic pustular folliculitis with a butterfly rash-like distribution. Dermatology 2004 0.75
207 Serum levels of manganese superoxide dismutase in patients with localized scleroderma. Exp Dermatol 2004 0.75
208 Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in a human T-cell leukaemia virus type-1 carrier. Acta Derm Venereol 2010 0.75
209 Anti-p53 antibodies in patients with systemic sclerosis. Int J Dermatol 2007 0.75
210 Systemic sclerosis with an unusual rapid development of huge calcinosis (tumoral calcinosis). J Dermatol 2011 0.75
211 Cytotoxic T lymphocyte antigen-4 gene (CTLA4) polymorphisms in Japanese patients with psoriasis vulgaris. J Dermatol Sci 2003 0.75
212 Severe generalized pustular psoriasis accompanied by bullae formation with increased serum vascular endothelial growth factor level. J Dermatol 2011 0.75
213 Psoriasis vulgaris associated with superior vena cava syndrome due to lung cancer metastasis. J Dermatol 2007 0.75
214 A case of primary cutaneous anaplastic large cell lymphoma with prominent epidermotropism. Int J Hematol 2012 0.75
215 Novel mutation (Asp158Val) in H1 domain of keratin 5 gene in a Japanese patient with Köbner-type epidermolysis bullosa simplex. J Dermatol 2006 0.75
216 A case of lichen sclerosus et atrophicus with marked fibrosis in the dermis: analysis of fibrogenetic cytokines by reverse transcriptase-polymerase chain reaction. J Dermatol 2004 0.75
217 Necrobiotic xanthogranuloma with paraproteinemia successfully treated with melphalan, prednisolone and skin graft. J Dermatol 2007 0.75
218 Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgaris. J Dermatol 2010 0.75
219 Elevated serum levels of manganese superoxide dismutase in patients with eosinophilic fasciitis. Clin Rheumatol 2003 0.75
220 Mycosis fungoides associated with intestinal mucosa-associated lymphoid tissue lymphoma. Int J Dermatol 2005 0.75
221 The lesional skin of linear IgA bullous dermatosis expresses growth-regulated peptide (GRO)-alpha. J Dermatol 2004 0.75
222 A keratin 9 Gene mutation (Asn160Ser) in a Japanese patient with epidermolytic palmoplantar keratoderma. J Dermatol 2002 0.75
223 Severe hyperkeratotic palmoplantar eczema (eczema tyloticum). J Dermatol 2009 0.75
224 Serum matrix metalloproteinase-3 in systemic sclerosis. Arch Dermatol Res 2004 0.75
225 Rheumatoid factor isotypes in mixed connective tissue disease. Clin Rheumatol 2006 0.75
226 Dermal endothelial cells express eotaxin in hypereosinophilic syndrome. J Am Acad Dermatol 2003 0.75
227 Labial melanotic macule diagnosed by dermoscopy. Acta Derm Venereol 2008 0.75
228 Rosai-Dorfman disease presenting as large pigmented indurated plaques. Acta Derm Venereol 2003 0.75
229 Langerhans cells do not produce interferon-gamma. J Invest Dermatol 2003 0.75
230 A novel keratin 9 gene mutation (Met156Arg) in a Japanese patient with epidermolytic palmoplantar keratoderma. Int J Dermatol 2006 0.75
231 Serum levels of soluble CD26 in patients with scleroderma. J Dermatol Sci 2008 0.75
232 Dermatofibrosarcoma protuberans with COL1A1-PDGFB fusion transcript arising on a scar due to a previous drainage tube insertion. J Dermatol 2008 0.75
233 Bilateral segmental neurofibromatosis. Acta Derm Venereol 2002 0.75
234 Diagnosis of epidermolytic palmoplantar keratoderma in a very early stage by gene analysis. J Dermatol 2005 0.75
235 Retrospective study of clinical and laboratory features in Japanese scleroderma patients with cardiac involvement. J Dermatol Sci 2009 0.75
236 Secondary cutaneous candidiasis with eosinophilia. J Dermatol 2010 0.75
237 Multiple eruptive dermatofibromas with CD34+ cells in a patient with hypertriglyceridemia. Dermatology 2003 0.75
238 Expression and regulation of RANTES/CCL5, MIP-1alpha/CCL3, and MIP-1beta/CCL4 in mouse Langerhans cells. J Invest Dermatol 2004 0.75